Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness

The European Lacidipine Study on Atherosclerosis

Rong Tang, Michael Hennig, M. Gene Bond, Regina Hollweck, Giuseppe Mancia, Alberto Zanchetti

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The European Lacidipine Study of Atherosclerosis (ELSA) was a prospective, randomized, double-blind, multinational interventional trial using B-mode ultrasound measurement of carotid intima-media thickness (IMT) in 2259 hypertensive individuals. ELSA showed that 4-year treatment with the calcium antagonist, lacidipine, significantly slowed down progression of carotid atherosclerosis as compared with treatment with the β-blocker, atenolol. Objective: To report data on cross-sectional and longitudinal quality control of the ultrasound measurements implemented throughout ELSA. Methods: Patients underwent scans at baseline and at each annual visit. All endpoints were measured while the study was in progress (initial measurements). In addition to the cross-sectional quality control procedures, a longitudinal quality control procedure of re-reading 250 baseline scans at yearly intervals was implemented, to control possible reader drift. After the study had been completed, the primary endpoint was measured again under the same condition of cross-sectional quality control. Results: Cross-sectional quality control data showed high reliability for all endpoints at all time points except for single maximum IMT (Tmax) and internal carotid IMT. Within-reader reliability was constantly better than between-reader reliability but, for the primary endpoint, between-reader reliability remained excellent. Initial and longitudinal quality control measurements showed a time trend toward lower IMT values. After application of a correction factor calculated from longitudinal quality control, all initial measurements no longer decreased with time, and the corrected IMT measurements were reasonably similar to those made after completion of the study. Conclusion: For long-term epidemiological studies and clinical trials, both cross-sectional and longitudinal quality control are critical to the reliability of measurements. In order to evaluate the absolute change in IMT and interpret study results without bias, both must be implemented.

Original languageEnglish
Pages (from-to)1047-1054
Number of pages8
JournalJournal of Hypertension
Volume23
Issue number5
Publication statusPublished - May 2005

Fingerprint

Carotid Intima-Media Thickness
Carotid Arteries
Ultrasonics
Quality Control
Atherosclerosis
Carotid Artery Diseases
Atenolol
lacidipine
Reading
Epidemiologic Studies
Clinical Trials
Calcium
Therapeutics

Keywords

  • Atherosclerosis
  • Carotid intima-media thickness
  • Clinical trial
  • Quality control
  • Ultrasound

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness : The European Lacidipine Study on Atherosclerosis. / Tang, Rong; Hennig, Michael; Bond, M. Gene; Hollweck, Regina; Mancia, Giuseppe; Zanchetti, Alberto.

In: Journal of Hypertension, Vol. 23, No. 5, 05.2005, p. 1047-1054.

Research output: Contribution to journalArticle

Tang, R, Hennig, M, Bond, MG, Hollweck, R, Mancia, G & Zanchetti, A 2005, 'Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness: The European Lacidipine Study on Atherosclerosis', Journal of Hypertension, vol. 23, no. 5, pp. 1047-1054.
Tang, Rong ; Hennig, Michael ; Bond, M. Gene ; Hollweck, Regina ; Mancia, Giuseppe ; Zanchetti, Alberto. / Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness : The European Lacidipine Study on Atherosclerosis. In: Journal of Hypertension. 2005 ; Vol. 23, No. 5. pp. 1047-1054.
@article{8cbb673a42da434c867993937ceaf98c,
title = "Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness: The European Lacidipine Study on Atherosclerosis",
abstract = "Background: The European Lacidipine Study of Atherosclerosis (ELSA) was a prospective, randomized, double-blind, multinational interventional trial using B-mode ultrasound measurement of carotid intima-media thickness (IMT) in 2259 hypertensive individuals. ELSA showed that 4-year treatment with the calcium antagonist, lacidipine, significantly slowed down progression of carotid atherosclerosis as compared with treatment with the β-blocker, atenolol. Objective: To report data on cross-sectional and longitudinal quality control of the ultrasound measurements implemented throughout ELSA. Methods: Patients underwent scans at baseline and at each annual visit. All endpoints were measured while the study was in progress (initial measurements). In addition to the cross-sectional quality control procedures, a longitudinal quality control procedure of re-reading 250 baseline scans at yearly intervals was implemented, to control possible reader drift. After the study had been completed, the primary endpoint was measured again under the same condition of cross-sectional quality control. Results: Cross-sectional quality control data showed high reliability for all endpoints at all time points except for single maximum IMT (Tmax) and internal carotid IMT. Within-reader reliability was constantly better than between-reader reliability but, for the primary endpoint, between-reader reliability remained excellent. Initial and longitudinal quality control measurements showed a time trend toward lower IMT values. After application of a correction factor calculated from longitudinal quality control, all initial measurements no longer decreased with time, and the corrected IMT measurements were reasonably similar to those made after completion of the study. Conclusion: For long-term epidemiological studies and clinical trials, both cross-sectional and longitudinal quality control are critical to the reliability of measurements. In order to evaluate the absolute change in IMT and interpret study results without bias, both must be implemented.",
keywords = "Atherosclerosis, Carotid intima-media thickness, Clinical trial, Quality control, Ultrasound",
author = "Rong Tang and Michael Hennig and Bond, {M. Gene} and Regina Hollweck and Giuseppe Mancia and Alberto Zanchetti",
year = "2005",
month = "5",
language = "English",
volume = "23",
pages = "1047--1054",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Quality control of B-mode ultrasonic measurement of carotid artery intima-media thickness

T2 - The European Lacidipine Study on Atherosclerosis

AU - Tang, Rong

AU - Hennig, Michael

AU - Bond, M. Gene

AU - Hollweck, Regina

AU - Mancia, Giuseppe

AU - Zanchetti, Alberto

PY - 2005/5

Y1 - 2005/5

N2 - Background: The European Lacidipine Study of Atherosclerosis (ELSA) was a prospective, randomized, double-blind, multinational interventional trial using B-mode ultrasound measurement of carotid intima-media thickness (IMT) in 2259 hypertensive individuals. ELSA showed that 4-year treatment with the calcium antagonist, lacidipine, significantly slowed down progression of carotid atherosclerosis as compared with treatment with the β-blocker, atenolol. Objective: To report data on cross-sectional and longitudinal quality control of the ultrasound measurements implemented throughout ELSA. Methods: Patients underwent scans at baseline and at each annual visit. All endpoints were measured while the study was in progress (initial measurements). In addition to the cross-sectional quality control procedures, a longitudinal quality control procedure of re-reading 250 baseline scans at yearly intervals was implemented, to control possible reader drift. After the study had been completed, the primary endpoint was measured again under the same condition of cross-sectional quality control. Results: Cross-sectional quality control data showed high reliability for all endpoints at all time points except for single maximum IMT (Tmax) and internal carotid IMT. Within-reader reliability was constantly better than between-reader reliability but, for the primary endpoint, between-reader reliability remained excellent. Initial and longitudinal quality control measurements showed a time trend toward lower IMT values. After application of a correction factor calculated from longitudinal quality control, all initial measurements no longer decreased with time, and the corrected IMT measurements were reasonably similar to those made after completion of the study. Conclusion: For long-term epidemiological studies and clinical trials, both cross-sectional and longitudinal quality control are critical to the reliability of measurements. In order to evaluate the absolute change in IMT and interpret study results without bias, both must be implemented.

AB - Background: The European Lacidipine Study of Atherosclerosis (ELSA) was a prospective, randomized, double-blind, multinational interventional trial using B-mode ultrasound measurement of carotid intima-media thickness (IMT) in 2259 hypertensive individuals. ELSA showed that 4-year treatment with the calcium antagonist, lacidipine, significantly slowed down progression of carotid atherosclerosis as compared with treatment with the β-blocker, atenolol. Objective: To report data on cross-sectional and longitudinal quality control of the ultrasound measurements implemented throughout ELSA. Methods: Patients underwent scans at baseline and at each annual visit. All endpoints were measured while the study was in progress (initial measurements). In addition to the cross-sectional quality control procedures, a longitudinal quality control procedure of re-reading 250 baseline scans at yearly intervals was implemented, to control possible reader drift. After the study had been completed, the primary endpoint was measured again under the same condition of cross-sectional quality control. Results: Cross-sectional quality control data showed high reliability for all endpoints at all time points except for single maximum IMT (Tmax) and internal carotid IMT. Within-reader reliability was constantly better than between-reader reliability but, for the primary endpoint, between-reader reliability remained excellent. Initial and longitudinal quality control measurements showed a time trend toward lower IMT values. After application of a correction factor calculated from longitudinal quality control, all initial measurements no longer decreased with time, and the corrected IMT measurements were reasonably similar to those made after completion of the study. Conclusion: For long-term epidemiological studies and clinical trials, both cross-sectional and longitudinal quality control are critical to the reliability of measurements. In order to evaluate the absolute change in IMT and interpret study results without bias, both must be implemented.

KW - Atherosclerosis

KW - Carotid intima-media thickness

KW - Clinical trial

KW - Quality control

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=18344392308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18344392308&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 1047

EP - 1054

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 5

ER -